Target- |
MechanismImmunomodulators |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
Clinical Evaluation of Metal Panel Allergens: Safety and Efficacy Study
Metal allergen patch test study.
Clinical Evaluation of Metal Panel Allergens: Aluminum, Copper, Manganese, Molybdenum, Tin, Titanium, Vanadium and Zinc Dose Response Study
48-hour application of metal allergen patches to test for potential allergic responses.
Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study
The purpose of this study is to evaluate the diagnostic performance and safety of ascending doses of mercury, aluminum and palladium metal allergens proposed for inclusion in a metal allergen panel. Optimal dose will be selected based on the lowest dose of each allergen eliciting a positive response in 70-90% of subjects tested.
100 Clinical Results associated with Allerderm Laboratories, Inc.
0 Patents (Medical) associated with Allerderm Laboratories, Inc.
100 Deals associated with Allerderm Laboratories, Inc.
100 Translational Medicine associated with Allerderm Laboratories, Inc.